Beta Drugs Ltd. received WHO- GMP approval for its API plant (Adley Labs Ltd.). This accreditation will open the door for accelerated growth in the coming years. It will not only help to consolidate company's API business in domestic market but also aid exports to Row markets and some of the semi Regulated countries thus paving way for increasing sales in the future. The company is also expanding its manufacturing capacity and working towards filing its DMF in mid of next year in the European market which will help the company to enter regulated markets. Further it is also working towards launching many new oncology APIs.